Universidade Estadual de Campinas (UNICAMP)

Running trials

• Not yet recruiting

  A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma

  NCT07882576· AstraZeneca· Source

• Not yet recruiting

  Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)

  NCT07681713· Phase 3· PTC Therapeutics· Source

• Not yet recruiting

  Pharmacokinetics of Zoledronic Acid in Patients on Dialysis

  NCT07741136· Phase 1· University of Campinas, Brazil· Source

• Recruiting

  A Study of TAK-755 in Adults With Acute Ischemic Stroke

  NCT07392450· Phase 2· Takeda· Source

• Recruiting

  A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

  NCT07285460· Phase 3· Sanofi· Source

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Clinical Course Of Disease In Participants With FA-CM

  NCT06865482· Lexeo Therapeutics· Source

• Active, not recruiting

  A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

  NCT06953583· Phase 3· Biogen· Source

• Active, not recruiting

  A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

  NCT06456580· Phase 3· Vor Biopharma· Source

• Recruiting

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  NCT06128629· Phase 3· Intellia Therapeutics· Source

• Recruiting

  Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

  NCT06016946· Friedreich's Ataxia Research Alliance· Source

• Recruiting

  Artificial Intelligence for Brain MRI Analysis in Epilepsy

  NCT07881185· Istituto Giannina Gaslini· Source

• Enrolling by invitation

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Recruiting

  Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  NCT05429632· Phase 3· Priothera SAS· Source

• Active, not recruiting

  A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

  NCT05071300· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

  NCT04023526· Phase 2· OncoVerity, Inc.· Source

• Recruiting

  Effects of a Pulmonary and Cardiovascular Rehabilitation Program

  NCT06772922· University of Campinas, Brazil· Source

• Active, not recruiting

  Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation

  NCT03173248· Phase 3· Institut de Recherches Internationales Servier· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis3 recruiting
• Friedreich ataxia3 recruiting
• Acute myeloid leukaemia1 recruiting
• Asthma1 recruiting
• Chronic kidney disease1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Epilepsy1 recruiting
• Haemophilia1 recruiting
• Heart failure1 recruiting
• Osteoporosis1 recruiting
• Stroke1 recruiting

Closed trials

• Recruiting

  A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

  NCT06319820· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes

  NCT04360720· Phase 3· Hospital Israelita Albert Einstein· Source

• Completed

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Completed

  Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)

  NCT04040634· Hospital Israelita Albert Einstein· Source

• Terminated

  PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia

  NCT03156790· Phase 2· medac GmbH· Source

• Completed

  A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

  NCT03652064· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response

  NCT02852486· Phase 2· University of Campinas, Brazil· Source

• Completed

  Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.

  NCT01467427· Phase 3· Novo Nordisk A/S· Source

• Completed

  Indolent Non Follicular Lymphomas Prognostic Project

  NCT02904577· Fondazione Italiana Linfomi - ETS· Source

Trial sites

• Campinas State University (UNICAMP)1 trial
• Center of Hematology and Hemotherapy, UNICAMP, University of Campinas1 trial
• Centro de Hematologia e Hemoterapia - Universidade Estadual de Campinas1 trial
• School of Medical Sciences, University of Campinas1 trial
• UNICAMP4 trials
• Unicamp Universidade Estadual de Campinas1 trial
• Universidade Estadual De Campinas8 trials
• Universidade Estadual de Campinas (UNICAMP)3 trials
• Universidade Estadual de Campinas (UNICAMP)- Site Number : 07600011 trial
• University of Campinas3 trials
• University of Campinas (UNICAMP) School of Medical Sciences1 trial
• Unicamp1 trial
• Universidade Estadual de Campinas1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Epilepsy38 works · 1 trial
• Haemophilia20 works · 2 trials
• Glaucoma19 works · 0 trials
• Cystic fibrosis18 works · 0 trials
• Sickle cell disease18 works · 0 trials
• Head and neck cancer17 works · 0 trials
• Acute lymphoblastic leukaemia12 works · 1 trial
• Thyroid cancer10 works · 0 trials
• Dystonia7 works · 0 trials
• Neuromyelitis optica (NMOSD)7 works · 0 trials
• Hydrocephalus7 works · 0 trials
• Spinal muscular atrophy7 works · 0 trials
• Chronic myeloid leukaemia7 works · 1 trial
• Friedreich ataxia6 works · 4 trials
• High blood pressure4 works · 1 trial
• Polycystic kidney disease3 works · 0 trials
• Restless legs syndrome3 works · 0 trials